Buchanan Professor of Genetics at the University of Edinburgh & a Fellow of the Royal Societies of London & Edinburgh. Director of the Wellcome Trust Centre for Cell Biology from 1999 to 2011. Governor of the Wellcome Trust from 2000-10 & Deputy Chairman from 2007. Currently trustee of Cancer Research UK & the Kirkhouse Trust. Awards include Howard Hughes International Fellowship, the Louis-Jeantet Prize for Medicine, the Gairdner Foundation prize and the Gabor & GSK Medals of the Royal Society.
2011-2017: Reader in Microbiology, Schools of Cellular & Molecular Medicine and Biochemistry, University of Bristol
2007-2011: as above, Senior Lecturer in Microbiology
2001-2007: Dunn School of Pathology, University of Oxford: Guy Newton Senior Research Fellow
1997-2000 : Institute Pasteur, Paris: Postdoctoral fellow
1996 : EMBL, Heidelberg: Postdoctoral fellow
1991-1995 : EMBL, Heidelberg: PhD in Cell Biology
1988-1991 : University College, London: B. Sc. in Genetics, 1st class
Professor for Biochemistry with Focus on electron Cryo Microscopy at the Julius Maximilians University Würzburg
INSERM Tenured Researcher in the field of Cardiovascular Research, currently focusing on therapeutic angiogenesis with polymer-based targeted growth factor delivery.
PhD in Tumor Biology (Pr Yihai Cao, Karolinska Institutet, Sweden), and expertise in Adipose tissue angiogenesis. Postdoc at UCLA (Pr Lily Wu) in molecular imaging and tumor lymphangiogenesis field.
Member of European Vascular Biology Organisation, French society for Cardiovascular Research, French society for Angiogenesis Research.
Professor of Anesthesiology at University of Rochester Medical Center. PhD in Biochemistry from Cambridge University (UK) and post-doctoral training at the University of Alabama at Birmingham. Research program in mitochondria, cardiac ischemia, and cardioprotective therapies.
Sarah Butcher did her PhD in EMBL Heidelberg, mentored by Stephen Fuller and Helen Saibil, she carried out postdoctoral training in the MRC Virology Unit in Glasgow, before moving to Helsinki University where she is currently Programme Director of the Structural Biology and Biophysics Programme, Institute of Biotechnology, Head of Instruct-FI National Affiliate Center, Finland & Head of National cryoEM facility. She works on macromolecular structure and assembly, especially of viruses.
PhD. Jesús Campos-García.
Professor-Researcher of Microbial Biotechnology Laboratory since 2003, at the Research Institute of Biological Chemistry of the Universidad Michoacana de San Nicolás de Hidalgo, México. He has authored over 80 papers in indexed and peer-reviewed journals. He was the recipient of the National Award for Young Researchers in 2008, for the Mexican Academy of Science. He possesses four Patents and several Technological processes transferred into the Industry.
Research areas are related to the study of the mechanisms of interaction of microorganisms such as Pseudomonas aeruginosa with the environment: mechanisms of organic compounds degradation, heavy metals resistance, host-pathogen interaction, microbial nano-bioactive metabolites, and genetic modification of industrial GEMs used for alcoholic fermentation and biofuels.
Awards
•National Award for Young Researchers in 2008, for the Mexican Academy of Science.
•State Award of Scientific Research in 2009, Michoacán State Government, México.
•Grant Marcos Moshinsky 2013-2014, Chemistry-Biological Sciences. Marcos Moshinsky Funding, México.
•Weizmann Award 2015, Nature Science. Mexican Academy of Science, to Randy Ortíz Castro by PhD thesis: Study of the N-acil-L-homoserin lactones and cyclodipeptides from bacteria of Pseudomonas genus in the plant development regulation.
•Member of the Mexican Academy of Science (since 2008).
•Member of the National System of Researchers (S.N.I.) since 1996.
Dr. Carrilho obtained his B.Sc. in Chemistry and M.Sc. in Analytical Chemistry from the University of São Paulo (USP) at São Carlos, Brazil, in 1987 and 1990, respectively. In 1997 he obtained his Ph.D. at the Northeastern University under the mentoring of Professor Barry L. Karger, from the Barnett Institute, in Boston, MA. He joined the faculty of the analytical chemistry program of the Institute of Chemistry at São Carlos, USP in 1998 where is full professor. During 2007-2009 he was a visiting professor at Harvard University in Professor George M. Whitesides group.
Dr. Carrilho’s group has been working on the development of new bioanalytical methods covering the broad aspects of genomics, proteomics, metabolomics for human health and applied microbiology in the search for cancer biomarkers and neglected tropical diseases. In the process translate the targeted biomarkers research to microfluidic platforms with biosensors and microchip electrophoresis for point-of-care applications. Recently, is developing microfluidic applications for low-cost diagnostics for developing countries using paper-based analytical devices (µPADs).
Dr. Chatti Abdelwaheb is an Associate Professor in Carthage University at the faculty of Sciences of Bizerte, Tunisia. He acquired his PhD from the University of Carthage in 2007. Dr. Chatti's research interests are primarily in the area of life and environmental sciences with emphasis on the use of microorganisms and biomaterials in remediation. He has over 50 peer reviewed research publications in leading journals.
Associate Professor at the Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary. Research Associate at the Department of Anesthesiology, University of Maryland, Baltimore, MD, USA during 2004. Academic Fellow at the Department of Anesthesiology, University of Maryland, Baltimore, MD, USA during 2002-2003. Primary field of interest: Bioenergetics, Mitochondriology.
Chaired Professor in Chemical and Biochemical Process Engineering, Lulea University of Technology, Associate Editor of World Journal of Microbiology and Biotechnology. Awarded an EU Marie Curie fellowship.
Post-doctoral work at NIH (virus fusion mechanisms) and EMBL to study cell biology (membrane trafficking). Moved to a faculty position at University of Liverpool. Early work focused on the role of phosphoinositide metabolism along the endocytic pathway then later the role of reversible ubiquitylation in endosomal sorting. This has lead to a broader interest in ubiquitin biology and the deubiquitylase family as potential drug targets.